These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33065253)

  • 1. Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.
    Lv W; Champion JA
    Nanomedicine; 2021 Feb; 32():102315. PubMed ID: 33065253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled protein nanocarrier for intracellular delivery of antibody.
    Lim SI; Lukianov CI; Champion JA
    J Control Release; 2017 Mar; 249():1-10. PubMed ID: 28069555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC.
    Chen P; Yang W; Hong T; Miyazaki T; Dirisala A; Kataoka K; Cabral H
    Biomaterials; 2022 Sep; 288():121748. PubMed ID: 36038419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
    Lee CS; Park W; Park SJ; Na K
    Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
    Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
    MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.
    Evans BC; Nelson CE; Yu SS; Beavers KR; Kim AJ; Li H; Nelson HM; Giorgio TD; Duvall CL
    J Vis Exp; 2013 Mar; (73):e50166. PubMed ID: 23524982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.
    Kilchrist KV; Dimobi SC; Jackson MA; Evans BC; Werfel TA; Dailing EA; Bedingfield SK; Kelly IB; Duvall CL
    ACS Nano; 2019 Feb; 13(2):1136-1152. PubMed ID: 30629431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular Trafficking.
    Yamada Y; Perez SM; Tabata M; Abe J; Yasuzaki Y; Harashima H
    J Pharm Sci; 2015 Sep; 104(9):2845-54. PubMed ID: 25546552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChAcNLS, a Novel Modification to Antibody-Conjugates Permitting Target Cell-Specific Endosomal Escape, Localization to the Nucleus, and Enhanced Total Intracellular Accumulation.
    Beaudoin S; Rondeau A; Martel O; Bonin MA; van Lier JE; Leyton JV
    Mol Pharm; 2016 Jun; 13(6):1915-26. PubMed ID: 27112376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide.
    Akishiba M; Takeuchi T; Kawaguchi Y; Sakamoto K; Yu HH; Nakase I; Takatani-Nakase T; Madani F; Gräslund A; Futaki S
    Nat Chem; 2017 Aug; 9(8):751-761. PubMed ID: 28754944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosomal escape efficiency of fusogenic B18 and B55 peptides fused with anti-EGFR single chain Fv as estimated by nuclear translocation.
    Niikura K; Horisawa K; Doi N
    J Biochem; 2016 Jan; 159(1):123-32. PubMed ID: 26338729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of a tumor cell-specific, cytosol-penetrating antibody with high endosomal escape efficacy.
    Kim JS; Park JY; Shin SM; Park SW; Jun SY; Hong JS; Choi DK; Kim YS
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2510-2516. PubMed ID: 30208519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic Protein Delivery for Intracellular Antigen Targeting Using Supercharged Polypeptide Delivery Platform.
    Wang Q; Yang Y; Liu D; Ji Y; Gao X; Yin J; Yao W
    Nano Lett; 2021 Jul; 21(14):6022-6030. PubMed ID: 34227381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.
    Goswami R; Jeon T; Nagaraj H; Zhai S; Rotello VM
    Trends Pharmacol Sci; 2020 Oct; 41(10):743-754. PubMed ID: 32891429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
    Wang J; Bhattacharyya J; Mastria E; Chilkoti A
    J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Intracellular Delivery of Antibodies in Cancer Cells with Nanocarriers Sensing Endo/Lysosomal Enzymatic Activity.
    Chen P; Yang W; Mochida Y; Li S; Hong T; Kinoh H; Kataoka K; Cabral H
    Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202317817. PubMed ID: 38342757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.
    El-Sayed A; Futaki S; Harashima H
    AAPS J; 2009 Mar; 11(1):13-22. PubMed ID: 19125334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding ways into the cytosol: Peptide-mediated approaches for delivering proteins into cells.
    Kawaguchi Y; Futaki S
    Curr Opin Chem Biol; 2024 Aug; 81():102482. PubMed ID: 38905721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal acidic pH-induced conformational changes of a cytosol-penetrating antibody mediate endosomal escape.
    Kim JS; Choi DK; Shin JY; Shin SM; Park SW; Cho HS; Kim YS
    J Control Release; 2016 Aug; 235():165-175. PubMed ID: 27264553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
    He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
    Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.